A comprehensive 2D CMC system was developed and applied to characterize active components from drug-containing serum for the first time.
A matrix interference deduction method effectively eliminated the interference of endogenous substances in serum.
Wogonin and oroxylin A screened both in vitro and in vivo, could be selected as anti-hepatoma leading compounds.
The methods had advantages in simplicity, sensitivity, accurate recognition and identification.